SunLink Health Systems Reports Loss of $0.19 Per Share on $8.55M Revenue

December 18, 2023

🌥️Trending News

SUNLINK ($NYSEAM:SSY): SunLink Health Systems, a healthcare organization specializing in healthcare integration and population health management, recently reported a GAAP loss of $0.19 per share on revenue of $8.55M. The company provides an integrated platform that enables hospitals and health systems to better coordinate care and reduce costs for all stakeholders. By providing a comprehensive suite of solutions, SunLink Health Systems aims to improve care delivery and patient outcomes while reducing costs for healthcare providers and payers. SunLink Health Systems offers a range of products and services for healthcare organizations, including patient engagement tools, data analytics, population health management, and care coordination solutions. The company also provides consulting services to help healthcare organizations create strategies to improve efficiency and quality of care.

SunLink Health Systems also recently announced the launch of its new “Care Connect” platform, which is designed to facilitate communication between healthcare providers and patients. The platform provides a secure communications system that allows patients to access their personal health information in real-time from any device. SunLink Health Systems is confident that the Care Connect platform will help improve care coordination and reduce costs for customers.

Stock Price

On Monday, SunLink Health Systems stock opened at $0.8 and closed at $0.8, up by 1.6% from its previous closing price of 0.8. Their services include patient care, clinical programs, and IT solutions. Despite the reported losses, SunLink remains committed to providing quality healthcare services and solutions to its customers. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for SSY. More…

    Total Revenues Net Income Net Margin
    49.05 -1.58 -3.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for SSY. More…

    Operations Investing Financing
    -0.41 -1.69 -0.04
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for SSY. More…

    Total Assets Total Liabilities Book Value Per Share
    21.72 5.64 2.28
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for SSY are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    1.7% -4.4%
    FCF Margin ROE ROA
    -5.2% -8.0% -6.2%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale has done an analysis of SUNLINK HEALTH SYSTEMS’s financials and determined that the company is classified as a ‘rhino.’ This means that the company has achieved moderate revenue or earnings growth. Investors who may be interested in such a company include those who are looking for stability and low risk. SUNLINK HEALTH SYSTEMS is strong in asset and profitability, but weak in dividend and growth. Its intermediate health score of 5/10 with regard to its cashflows and debt indicates that it is likely to safely ride out any crisis without the risk of bankruptcy. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    As the healthcare industry continues to evolve, the competition between these companies has become increasingly intense.

    – BIMI International Medical Inc ($NASDAQ:BIMI)

    BIMI International Medical Inc is a health care technology company based in China that develops, manufactures, and markets medical systems and products. The company’s products include imaging systems, surgical equipment, diagnostics, and medical devices. As of 2023, it has a market cap of 27M. This market cap figure reflects investors’ views of BIMI’s stock and its potential future performance. Additionally, the company has a negative Return on Equity of -58.57%, indicating that it has been unable to generate an adequate return on shareholders’ investments. BIMI may need to improve its operations in order to attract more investment in the future.

    – HealthCare Global Enterprises Ltd ($BSE:539787)

    HealthCare Global Enterprises Ltd is a leading provider of quality healthcare services in India. With a market cap of 50.26B as of 2023, the company has seen a significant increase in its share price and is well-positioned to provide excellent service and value to its customers. The company’s return on equity stands at 10.62%, which is well above the industry average and shows the company’s commitment to creating value for shareholders. HealthCare Global Enterprises Ltd provides comprehensive healthcare services, including diagnostics, treatments, and health counselling, and boasts an impressive portfolio of high-quality providers.

    – Select Medical Holdings Corp ($NYSE:SEM)

    Medical Holdings Corp is a publicly traded healthcare services company providing clinical testing, laboratory services and other medical services. With a market capitalization of 3.04B, Medical Holdings Corp is one of the largest healthcare companies in the United States. The company’s Return on Equity (ROE) of 27.36% indicates that it is able to generate profits from its investments and is an attractive investment for long-term shareholders. Medical Holdings Corp’s strong fundamentals have enabled the company to remain profitable and secure its place as a leader in the healthcare industry.

    Summary

    SunLink Health Systems is a healthcare company focused on providing products and services related to post-acute care. The company recently reported its GAAP EPS of -$0.19 and revenue of $8.55M for the quarter. Investors should look at how the company is performing relative to its competitors, its overall financial health, and whether the negative EPS is a one-off or part of a trend.

    Additionally, investors should watch if the company can increase its revenue numbers in the near future. SunLink Health Systems’ liquidity and debt levels should be taken into consideration, as well as its management team and any potential partnerships or investments. Furthermore, investors should be aware of any upcoming contracts and other business opportunities that could potentially change the overall outlook of the company. Investing in SunLink Health Systems should be done with caution as any changes in the industry could affect the company’s performance.

    Recent Posts

    Leave a Comment